Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7319)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2022 (publication date) through May 23, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Smith C, Zheng W, Dong J, Wang Y, Lai J, Liu X, Yin F. Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. World J Gastroenterol 2022; 28(27): 3297-3313 [PMID: 36158269 DOI: 10.3748/wjg.v28.i27.3297] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i27/3297.htm |
| Number | Citing Articles |
| 1 |
Jiayue Zeng, Yijing Liu, Chenfei Dong, Suli Chong, Yang Liu, Ziming Bian, Xiaoming Chen, Sairong Fan. Sialyltransferase ST3GAL4 directs a dual mechanism to promote pancreatic ductal adenocarcinoma progression by regulating endoplasmic reticulum stress and mitochondrial homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(6): 167900 doi: 10.1016/j.bbadis.2025.167900
|
| 2 |
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, Giulia de Martino, Vanessa Desantis. Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions. Cancers 2024; 16(13): 2438 doi: 10.3390/cancers16132438
|
| 3 |
Xiaofei Cheng, Wenguang He, Weixiang Zhong, Congke Tong, Guosheng Wu. Immunotherapy as a promising treatment strategy for dmmr colorectal cancer with brain metastasis: a case report. Journal of Cancer Metastasis and Treatment 2023; doi: 10.20517/2394-4722.2023.85
|
| 4 |
You-Na Sung. Tissue inhibitor of metalloproteinase 1 as a biomarker of venous invasion in pancreatic ductal adenocarcinoma. American Journal of Cancer Research 2025; 15(3): 1248 doi: 10.62347/OVUJ4436
|
| 5 |
Lingyun Feng, Lijuan Guo, Yoshimasa Tanaka, Li Su. Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance. International Journal of Molecular Sciences 2022; 23(23): 15236 doi: 10.3390/ijms232315236
|
| 6 |
Diego J. Jiménez, Aadil Javed, Teresa Rubio-Tomás, Ndioba Seye-Loum, Carles Barceló. Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. International Journal of Molecular Sciences 2024; 25(5): 2860 doi: 10.3390/ijms25052860
|
| 7 |
Kadir Çorbacı, Meryem Gunay Gurleyik, Aylin Gonultas, Fugen Aker, Mehmet Onur Gul, Metin Tilki. Evaluation of prognostic significance of histopathological characteristics and tumor-infiltrating lymphocytes for pancreatic cancer survival. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-79342-x
|
| 8 |
Yong Sun, Hong Wan, Jie Xiong, Kun Cao, Dashuai Yang, Jun Huang. Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1559909
|
| 9 |
Mengyang Ding, Jingyu Liu, Honghui Lv, Yanlin Zhu, Yumiao Chen, Hui Peng, Sairong Fan, Xiaoming Chen. Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1097772
|
| 10 |
Wisdom O. Maduabuchi, Felista L. Tansi, Bernd Faenger, Paul Southern, Quentin A. Pankhurst, Frank Steiniger, Martin Westermann, Ingrid Hilger. Local Magnetic Hyperthermia and Systemic Gemcitabine/Paclitaxel Chemotherapy Triggers Neo-Angiogenesis in Orthotopic Pancreatic Tumors without Involvement of Auto/Paracrine Tumor Cell VEGF Signaling and Hypoxia. Cancers 2023; 16(1): 33 doi: 10.3390/cancers16010033
|
| 11 |
Ana Bogut, Bojan Stojanovic, Marina Jovanovic, Milica Dimitrijevic Stojanovic, Nevena Gajovic, Bojana S. Stojanovic, Goran Balovic, Milan Jovanovic, Aleksandar Lazovic, Milos Mirovic, Milena Jurisevic, Ivan Jovanovic, Violeta Mladenovic. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. International Journal of Molecular Sciences 2023; 24(21): 15500 doi: 10.3390/ijms242115500
|
| 12 |
Kun Wang, Huayan Wen, Caiyun Liu, Zilu Li, Siqi Wang, Hanchuang Zhu, Mengyuan Liu, Xiaodi Rong, Miaohui Yu, Wenlong Sheng, Baocun Zhu. An afatinib-based theranostic fluorescent probe for cancer cells and its applications in monitoring pH changes during treatment. Sensors and Actuators B: Chemical 2025; 426: 137056 doi: 10.1016/j.snb.2024.137056
|
| 13 |
Junwen Zhou, Kunping Yang, Mei Lu, Peiling Fu, Yupeng Chen, Linying Chen. Higher density of compact B cell clusters in invasive front may contribute to better prognosis in pancreatic ductal adenocarcinoma. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02260-5
|
| 14 |
Soyeon Yi, Kyunghee Noh, Hyeran Kim, Eunkyeong Jung, Suhyeon Kim, Jieun Lee, Kyeonghye Guk, Jinsol Choi, Eun-Kyung Lim, Seokho Kim, Hwangseo Park, Jung Hwa Lim, Cho-Rok Jung, Taejoon Kang, Juyeon Jung. Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation. Molecular Cancer 2025; 24(1) doi: 10.1186/s12943-025-02325-7
|
| 15 |
Jee-Hyung Lee, Sang-Hyub Lee, Sang-Kook Lee, Jin-Ho Choi, Seohyun Lim, Min-Song Kim, Kyung-Min Lee, Min-Woo Lee, Ja-Lok Ku, Dae-Hyun Kim, In-Rae Cho, Woo-Hyun Paik, Ji-Kon Ryu, Yong-Tae Kim. Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells. Cancers 2023; 15(9): 2642 doi: 10.3390/cancers15092642
|
| 16 |
Ann Mary Joseph, Ahmad Al Aiyan, Basel Al-Ramadi, Shiv K. Singh, Uday Kishore. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1323198
|